Prophylactic β‐blocker therapy: Clinical implications of an aggregate analysis
Jorge J. Gumucio, Thomas F. Imperiale, Arthur J. McCullough – 1 February 1992 – Background. The value of beta‐adrenergic‐antagonist drug therapy for the prevention of initial episodes of gastrointestinal bleeding in patients with cirrhosis and esophageal varices is uncertain, both positive and negative study results having been reported.